Optimization of (2,3-Dihydro-1-benzofuran-3-yl)acetic Acids: Discovery of a Non-Free Fatty Acid-Like, Highly Bioavailable G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist as a Glucose-Dependent Insulinotropic Agent

被引:70
作者
Negoro, Nobuyuki [2 ]
Sasaki, Shinobu [2 ]
Mikami, Satoshi [2 ]
Ito, Masahiro [2 ]
Tsujihata, Yoshiyuki [2 ]
Ito, Ryo [2 ]
Suzuki, Masami [2 ]
Takeuchi, Koji [2 ]
Suzuki, Nobuhiro [1 ]
Miyazaki, Junichi [1 ]
Santou, Takashi [2 ]
Odani, Tomoyuki [2 ]
Kanzaki, Naoyuki [2 ]
Funami, Miyuki [1 ]
Morohashi, Akio [2 ]
Nonaka, Masami [2 ]
Matsunaga, Shinichiro [2 ]
Yasuma, Tsuneo [1 ]
Momose, Yu [2 ]
机构
[1] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan
[2] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan
关键词
BETA-CELLS; SECRETION; GPR40; TAK-875;
D O I
10.1021/jm300170m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
G protein-coupled receptor 40 (GPR40)/free fatty acid receptor 1 (FFA1) is a free fatty acid (FFA) receptor that mediates FFA-amplified glucose-stimulated insulin secretion in pancreatic beta-cells. We previously identified (2,3-dihydro-1-benzofuran-3-yl)acetic acid derivative 2 as a candidate, but it had relatively high lipophilicity. Adding a polar functional group on 2 yielded several compounds with lower lipophilicity and little effect on caspase-3/7 activity at 30 mu M (a marker of toxicity in human HepG2 hepatocytes). Three optimized compounds showed promising pharmacokinetic profiles with good in vivo effects. Of these, compound 16 had the lowest lipophilicity. Metabolic analysis of 16 showed a long-acting PK profile due to high resistance to beta-oxidation. Oral administration of 16 significantly reduced plasma glucose excursion and increased insulin secretion during an OGTT in type 2 diabetic rats. Compound 16 (TAK-875) is being evaluated in human clinical trials for the treatment of type 2 diabetes.
引用
收藏
页码:3960 / 3974
页数:15
相关论文
共 29 条
[1]  
[Anonymous], IDF DIAB ATL
[2]   The action of aluminium chloride on some phenol homologues [J].
Baddeley, G .
JOURNAL OF THE CHEMICAL SOCIETY, 1943, :527-531
[3]   Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes [J].
Bharate, Sandip B. ;
Nemmani, Kumar V. S. ;
Vishwakarma, Ram A. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (02) :237-264
[4]   The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids [J].
Briscoe, CP ;
Tadayyon, M ;
Andrews, JL ;
Benson, WG ;
Chambers, JK ;
Eilert, MM ;
Ellis, C ;
Elshourbagy, NA ;
Goetz, AS ;
Minnick, DT ;
Murdock, PR ;
Sauls, HR ;
Shabon, U ;
Spinage, LD ;
Strum, JC ;
Szekeres, PG ;
Tan, KB ;
Way, JM ;
Ignar, DM ;
Wilson, S ;
Muir, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11303-11311
[5]   Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets [J].
Del Guerra, S ;
Marselli, L ;
Lupi, R ;
Boggi, U ;
Mosca, F ;
Benzi, L ;
Del Prato, S ;
Marchetti, P .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2005, 19 (01) :60-64
[6]   Pharmacological agents that directly modulate insulin secretion [J].
Doyle, ME ;
Egan, JM .
PHARMACOLOGICAL REVIEWS, 2003, 55 (01) :105-131
[7]   Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet β-cells:: mediation by PLC and L-type Ca2+ channel and link to insulin release [J].
Fujiwara, K ;
Maekawa, F ;
Yada, T .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (04) :E670-E677
[8]   o-Formylation of electron-rich phenols with dichloromethyl methyl ether and TiCl4 [J].
García, O ;
Nicolás, E ;
Albericio, F .
TETRAHEDRON LETTERS, 2003, 44 (27) :4961-4963
[9]   Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 [J].
Itoh, Y ;
Kawamata, Y ;
Harada, M ;
Kobayashi, M ;
Fujii, R ;
Fukusumi, S ;
Ogi, K ;
Hosoya, M ;
Tanaka, Y ;
Uejima, H ;
Tanaka, H ;
Maruyama, M ;
Satoh, R ;
Okubo, S ;
Kizawa, H ;
Komatsu, H ;
Matsumura, F ;
Noguchi, Y ;
Shinobara, T ;
Hinuma, S ;
Fujisawa, Y ;
Fujino, M .
NATURE, 2003, 422 (6928) :173-176
[10]   Cell death assays for drug discovery [J].
Kepp, Oliver ;
Galluzzi, Lorenzo ;
Lipinski, Marta ;
Yuan, Junying ;
Kroemer, Guido .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (03) :221-237